Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

JP Venetz, JD Aubert, C Seydoux, M Pascual - Transplantation …, 2005 - Elsevier
Valganciclovir (VGC) has proved efficacious and safe for the prophylaxis against
cytomegalovirus (CMV) in high-risk transplant recipients and for the treatment of CMV …
被引用次数：56 相关文章
[PDF] psu.edu

[PDF][PDF] Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir

JP Venetz, JD Aubert, P Meylan - American Journal of Transplantation, 2005 - Citeseer
We read with great interest the recently published American Society of Transplantation
guidelines and the report of the Canadian Society of Transplantation consensus workshop …

[引用][C] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

J FELLAY, JP VENETZ, JD AUBERT… - Transplantation …, 2005 - pascal-francis.inist.fr
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with
valganciclovir CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

J Fellay, JP Venetz, JD Aubert, C Seydoux… - Transplantation …, 2005 - europepmc.org
Valganciclovir (VGC) has proved efficacious and safe for the prophylaxis against
cytomegalovirus (CMV) in high-risk transplant recipients and for the treatment of CMV …

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

J Fellay, JP Venetz, JD Aubert, C Seydoux, M Pascual… - 2005 - cabidigitallibrary.org
Valganciclovir (VGC) has proved efficacious and safe for the prophylaxis against
cytomegalovirus (CMV) in high-risk transplant recipients and for the treatment of CMV …

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

J Fellay, JP Venetz, JD Aubert, C Seydoux… - Transplantation …, 2005 - folia.unifr.ch
English Valganciclovir (VGC) has proved efficacious and safe for the prophylaxis against
cytomegalovirus (CMV) in high-risk transplant recipients and for the treatment of CMV …
[HTML] amjtransplant.org

[HTML][HTML] Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir

J Fellay, JP Venetz, M Pascual, JD Aubert… - American Journal of …, 2005 - amjtransplant.org
We read with great interest the recently published American Society of Transplantation
guidelines and the report of the Canadian Society of Transplantation consensus workshop …

[引用][C] Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

J Fellay, JP Venetz, M Pascual… - American journal of …, 2005 - infoscience.epfl.ch
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with
valganciclovir English Français login Menu Search Browse Collections Help English Français …
[PDF] academia.edu

[PDF][PDF] Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir

J Fellay, JP Venetz, M Pascual… - American Journal of …, 2005 - academia.edu
We read with great interest the recently published American Society of Transplantation
guidelines and the report of the Canadian Society of Transplantation consensus workshop …

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

J Fellay, JP Venetz, JD Aubert… - Transplantation …, 2005 - pubmed.ncbi.nlm.nih.gov
Valganciclovir (VGC) has proved efficacious and safe for the prophylaxis against
cytomegalovirus (CMV) in high-risk transplant recipients and for the treatment of CMV …